

Quest has approximately 150 laboratories and 2000 patient service centers. It processes over 140 million requisitions per year. At present, routine testing generates about 78% of revenues. The company is based in Teterboro, NJ and GlaxoSmithkline owns about 21% of the common stock.
Although, United Health has decided to use Lab Corp of America as its national provider, a position that Quest enjoyed previously, it is uncertain how negative this will be to the revenues of Quest. Although shares have fallen about 15% since Septenber 2006, I feel that the drop in shares, combined with the high ROIC provide an enticing entry point.
I haven't bought any shares of Quest but I am certainly considering the stock at this point.
I am continuing to research the stock at this point and will provide my new findings soon.
1 comment:
So have you bought the stock yet ?
Post a Comment